These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 17619998)

  • 1. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development.
    Ohtsuki S; Terasaki T
    Pharm Res; 2007 Sep; 24(9):1745-58. PubMed ID: 17619998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multi-disciplinary research approaches on the brain barrier transport system, a dynamic interface].
    Tachikawa M; Uchida Y; Terasaki T
    Brain Nerve; 2013 Feb; 65(2):121-36. PubMed ID: 23399670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular mechanisms of drug influx and efflux transport at the blood-brain barrier].
    Ohtsuki S; Hori S; Terasaki T
    Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):55-64. PubMed ID: 12843573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transporter-mediated permeation of drugs across the blood-brain barrier.
    Tamai I; Tsuji A
    J Pharm Sci; 2000 Nov; 89(11):1371-88. PubMed ID: 11015683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physiological function of blood-brain barrier transporters as the CNS supporting and protecting system].
    Ohtsuki S
    Yakugaku Zasshi; 2004 Nov; 124(11):791-802. PubMed ID: 15516806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New aspects of the blood-brain barrier transporters; its physiological roles in the central nervous system.
    Ohtsuki S
    Biol Pharm Bull; 2004 Oct; 27(10):1489-96. PubMed ID: 15467183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in brain penetration evaluation in drug discovery and development.
    Liu X; Chen C; Smith BJ
    J Pharmacol Exp Ther; 2008 May; 325(2):349-56. PubMed ID: 18203948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane transporter proteins: a challenge for CNS drug development.
    Girardin F
    Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABC transporters and drug efflux at the blood-brain barrier.
    Shen S; Zhang W
    Rev Neurosci; 2010; 21(1):29-53. PubMed ID: 20458886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demystifying brain penetration in central nervous system drug discovery. Miniperspective.
    Di L; Rong H; Feng B
    J Med Chem; 2013 Jan; 56(1):2-12. PubMed ID: 23075026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
    Löscher W; Potschka H
    Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug transport across the blood-brain barrier and the impact of breast cancer resistance protein (ABCG2).
    Nicolazzo JA; Katneni K
    Curr Top Med Chem; 2009; 9(2):130-47. PubMed ID: 19200001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of experimental models of the blood-brain barrier in CNS drug discovery.
    Palmer AM; Alavijeh MS
    Curr Protoc Pharmacol; 2013 Oct; 62():7.15.1-7.15.30. PubMed ID: 24510719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Nicotine Transport across the Blood-Brain Barrier: Carrier-Mediated Transport of Nicotine and Interaction with Central Nervous System Drugs.
    Tega Y; Yamazaki Y; Akanuma SI; Kubo Y; Hosoya KI
    Biol Pharm Bull; 2018; 41(9):1330-1336. PubMed ID: 30175770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-brain barrier active efflux transporters: ATP-binding cassette gene family.
    Löscher W; Potschka H
    NeuroRx; 2005 Jan; 2(1):86-98. PubMed ID: 15717060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease.
    Di Marco A; Gonzalez Paz O; Fini I; Vignone D; Cellucci A; Battista MR; Auciello G; Orsatti L; Zini M; Monteagudo E; Khetarpal V; Rose M; Dominguez C; Herbst T; Toledo-Sherman L; Summa V; Muñoz-Sanjuán I
    Mol Pharm; 2019 May; 16(5):2069-2082. PubMed ID: 30916978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery.
    Pardridge WM
    Expert Opin Ther Targets; 2015; 19(8):1059-72. PubMed ID: 25936389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significant role of poloxamer in drug transport across blood-brain barrier].
    Zhang W; Fang XL
    Yao Xue Xue Bao; 2008 Sep; 43(9):890-7. PubMed ID: 19048778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The blood-brain barrier: clinical implications for drug delivery to the brain.
    De Boer AG; Breimer DD
    J R Coll Physicians Lond; 1994; 28(6):502-6. PubMed ID: 7884704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method to predict different mechanisms for blood-brain barrier permeability of CNS activity compounds in Chinese herbs using support vector machine.
    Jiang L; Chen J; He Y; Zhang Y; Li G
    J Bioinform Comput Biol; 2016 Feb; 14(1):1650005. PubMed ID: 26632324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.